Autonomic Pharm I Flashcards
primary result of alpha-1 activation?
vasoconstriction by activation of smooth muscle
alpha-1 specific antagonists?
Doxazosin, Terazosin, Prazosin
balanced alpha-1/alpha-2 antagonists?
Phenoxybenzamine, Phentolamine
subtypes of alpha-1 receptors?
alpha-1a, alpha-1b, alpha-1d
location of alpha-1a receptors?
bladder neck and prostate, blockade can improve symptoms of BPH and improve urine flow
Stimulation of alpha-1 receptors induces vasoconstriction in these in vessels
vasculature of the skeletal muscle and skin, and the splachnic vessels
synaptic location of alpha-1 receptors?
post-synaptic membrane, mediates downstream events
synaptic location of alpha-2 receptors?
pre-synaptic terminal, functions as auto-receptor to terminate further NE release
activation of alpha-2 receptors produces?
agonists produce bradycardia and hypotension, they terminate further NE release
blockade of alpha-1 receptors causes?
lower blood pressure, prevents NE-stimulated smooth muscle contraction in the vasculature
Which alpha antagonist requires more than one daily dosing?
Prazosin
Alpha antagonist most correlated with first dose orthostatic hypotension?
Prazosin
Alpha antagonists that are more likely to cause sinus tachycarida?
Non-specific blockers, by virtue of augmenting action of endogenous NE release by inhibiting alpha-2
Phenoxybenzamine mechanism?
Binds covalently (me last you long time) to both alpha-1 and alpha-2
Phenoxybenzamine effect on blood pressure?
reduction via vasodilation, but less substantially than alpha-1 specific antagonists due to increased cardiac output seen with alpha-2 inhibition
Indications of Phenoxybenzamine?
Pheochromocytoma and “off label” use for Raynaud’s Syndrome
Mechanism of Phentolamine?
Non-specific, competitive alpha antagonist (short-acting)
Cardio-stimulation with Phentolamine?
Yes, due to antagonism of alpha-2